Tri Locum Partners LP Leap Therapeutics, Inc. Transaction History

Tri Locum Partners LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.92 - $9.3 $654,854 - $6.62 Million	711,798 New	711,798 $626,000
Q2 2022 Aug 15, 2022	SELL	$0.96 - $1.91 $1.16 Million - $2.31 Million	-1,206,897 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.6 - $3.35 $1.93 Million - $4.04 Million	1,206,897 New	1,206,897 $2.11 Million
Q4 2021 Feb 14, 2022	SELL	$2.08 - $3.65 $3.77 Million - $6.61 Million	-1,810,672 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.35 - $4.01 $2.44 Million - $7.26 Million	1,810,672 New	1,810,672 $7.26 Million

265K

Ticker LPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,021,400
Market Cap $344M
Description
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...

Get notified when there are updates to the investment portfolio of Tri Locum Partners LP, based on Form 13F filings with the SEC.

Stay updated on Tri Locum Partners LP with notifications on news.